{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:28:25Z","timestamp":1760099305069,"version":"3.43.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1023\/a:1019552602793","type":"journal-article","created":{"date-parts":[[2003,3,13]],"date-time":"2003-03-13T18:25:54Z","timestamp":1047579954000},"page":"563-569","source":"Crossref","is-referenced-by-count":8,"title":["Hypertension in the elderly"],"prefix":"10.1007","volume":"33","author":[{"given":"Manuel","family":"Pestana","sequence":"first","affiliation":[]}],"member":"297","reference":[{"key":"402009_CR1","first-page":"35","volume":"24","author":"FH. Messerli","year":"1985","unstructured":"Messerli FH. Essencial hypertension in the elderly. Triangle 1985; 24: 35\u201347","journal-title":"Triangle"},{"key":"402009_CR2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1161\/01.HYP.25.3.305","volume":"25","author":"VL Burt","year":"1995","unstructured":"Burt VL, Whelton P, Roccella EJ et al. Prevalence of hyper-tension in the US adult population. Results from the Third National Health and Nutrition Examination Survey 1988\u201391. Hypertension 1995; 25: 305\u2013313","journal-title":"Hypertension"},{"key":"402009_CR3","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/00004872-200018050-00012","volume":"18","author":"G Grassi","year":"2000","unstructured":"Grassi G, Seravalle G, Bertinieri G et al. Sympathetic and reflex alterations in systo-diastolic and systolic hypertension of the elderly. J Hypertens 2000; 18: 587\u2013593","journal-title":"J Hypertens"},{"key":"402009_CR4","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/00004872-200018090-00001","volume":"18","author":"ME Safar","year":"2000","unstructured":"Safar ME, Rudnichi A, Asmar R. Drug treatment of hyper-tension: the reduction of pulse pressure does not necessarily parallel that of systolic and diastolic blood pressure. J Hyper-tens 2000; 18: 1159\u20131163","journal-title":"J Hyper-tens"},{"key":"402009_CR5","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/01.STR.31.3.782","volume":"31","author":"ME Safar","year":"2000","unstructured":"Safar ME, Blacher J, Mourad JJ et al. Stiffness of carotid artery wall material and blood pressure in humans. Stroke 2000; 31: 782\u2013790","journal-title":"Stroke"},{"key":"402009_CR6","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(83)90977-7","volume":"2","author":"FH Messerli","year":"1983","unstructured":"Messerli FH, Ventura HO, Glade LB et al. Essential hyper-tension in the elderly: haemodinamics, intravascular volume, plasma rennin activity, and circulating catecholamine levels. Lancet 1983; 2: 983\u2013986","journal-title":"Lancet"},{"key":"402009_CR7","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/ndt\/16.6.1095","volume":"16","author":"PA. van Zwieten","year":"2001","unstructured":"van Zwieten PA. Drug treatment of isolated systolic hyperten-sion. Nephrol Dial Transplant 2001; 16: 1095\u20131097","journal-title":"Nephrol Dial Transplant"},{"key":"402009_CR8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/01.HYP.21.3.335","volume":"21","author":"Systolic Hypertension in the Elderly Program Cooperative Research Group.","year":"1993","unstructured":"Systolic Hypertension in the Elderly Program Cooperative Research Group. Implications of the Systolic Hypertension in the Elderly Program. Hypertension 1993; 21: 335\u2013343","journal-title":"Hypertension"},{"key":"402009_CR9","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jama.1981.03310370017013","volume":"45","author":"WB Kannel","year":"1981","unstructured":"Kannel WB, Wolf PA, McGee DL et al. Systolic blood pres-sure, arterial rigidity and risk of stroke: The Framingham Study. J Am Med Assoc 1981; 45: 1225\u20131229","journal-title":"J Am Med Assoc"},{"key":"402009_CR10","first-page":"573","volume":"54","author":"WB Kannel","year":"1978","unstructured":"Kannel WB, Gordon T. Evaluation of cardiovascular risk in the elderly: The Framingham Study. Bull NY Acad Med 1978; 54: 573\u2013591","journal-title":"Bull NY Acad Med"},{"key":"402009_CR11","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3109\/10641969309037085","volume":"15","author":"S MacMahon","year":"1993","unstructured":"MacMahon S, Rodgers A. The effects of blood pressure reduc-tion in older patients. An overview of five controlled trials in elderly hypertensives. Clin Exp Hypertens 1993; 15: 967\u2013978","journal-title":"Clin Exp Hypertens"},{"key":"402009_CR12","first-page":"1125","volume":"78","author":"AM. Ostfeld","year":"1978","unstructured":"Ostfeld AM. Elderly hypertensive patient. NY State J Med 1978; 78: 1125","journal-title":"NY State J Med"},{"key":"402009_CR13","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM197210192871601","volume":"287","author":"WB Kannel","year":"1972","unstructured":"Kannel WB, Castelli WP, McNamara PM et al. Role of blood pressure in the development of congestive failure: The Framingham Study. N Engl J Med 1972; 287: 781\u2013787","journal-title":"N Engl J Med"},{"key":"402009_CR14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/oxfordjournals.aje.a114008","volume":"121","author":"H. DetectionFollow-up Program","year":"1985","unstructured":"Hypertension Detection and Follow-up Program. Detection and treatment of hypertension in older individuals. Am J Epidemiol 1985; 121: 371\u2013376","journal-title":"Am J Epidemiol"},{"key":"402009_CR15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/archinte.1992.00400130082009","volume":"152","author":"JD Neaton","year":"1992","unstructured":"Neaton JD, Wentworth D. Serum cholesterol, blood pres-sure, cigarette smoking and death from coronary heart disease. Overall findings and differences by age for 316099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch Int Med 1992; 152: 56\u201364","journal-title":"Arch Int Med"},{"key":"402009_CR16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/01.CIR.45.5.991","volume":"45","author":"A. C. S. o. A. A. Veterans","year":"1972","unstructured":"Veterans Administration Co-operative Study on Antihyper-tensive Agents. Effects of treatment on morbidity in hyper-tension. III: Influence of age, diastolic pressure and prior cardiovascular disease. Circulation 1972; 45: 991\u20131004","journal-title":"Circulation"},{"key":"402009_CR17","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0140-6736(85)91783-0","volume":"2","author":"A Amery","year":"1985","unstructured":"Amery A, Birkenhager W, Brixko P et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet 1985; 2: 1349\u20131354","journal-title":"Lancet"},{"key":"402009_CR18","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/0140-6736(91)92589-T","volume":"338","author":"B Dahlof","year":"1991","unstructured":"Dahlof B, Lindholm L, Hansson L et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hyperten-sion (STOP-Hypertension). Lancet 1991; 338: 1281\u20131285","journal-title":"Lancet"},{"key":"402009_CR19","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","volume":"351","author":"L Hansson","year":"1998","unstructured":"Hansson L, Zanchetti A, Carruthers SG et al. Effects of intensive blood-pressure lowering and low dose aspirin in patients with hypertension: principal results of the Hyperten-sion Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998; 351: 1755\u20131762","journal-title":"Lancet"},{"key":"402009_CR20","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.279.23.1903","volume":"279","author":"FH Messerli","year":"1998","unstructured":"Messerli FH, Grossman E, Goldbourt U. Are \u00e2-blockers effic-acious as first line therapy for hypertension in the elderly? A systematic review. JAMA 1998; 279: 1903\u20131907","journal-title":"JAMA"},{"key":"402009_CR21","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","volume":"265","author":"SHEP Cooperative Research Group.","year":"1991","unstructured":"SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991; 265: 3255\u20133264","journal-title":"JAMA"},{"key":"402009_CR22","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(97)05381-6","volume":"350","author":"SYST-EUR Trial Investigators.","year":"1997","unstructured":"SYST-EUR Trial Investigators. Randomized double blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350: 757\u2013764","journal-title":"Lancet"},{"key":"402009_CR23","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(98)03086-4","volume":"352","author":"F Forette","year":"1998","unstructured":"Forette F, Seux ML, Staessen JA. Prevention of dementia in randomised double blind placebo-controlled systolic hyper-tension in Europe (SYST-EUR) trial. Lancet 1998; 352: 1347\u20131351","journal-title":"Lancet"},{"key":"402009_CR24","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/00004872-199816120-00016","volume":"16","author":"J Liu","year":"1998","unstructured":"Liu J, Wang GJ, Gong L et al. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (SYST-China) collaborative study. J Hypertens 1998; 16: 1823\u20131829","journal-title":"J Hypertens"},{"key":"402009_CR25","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0140-6736(00)02527-7","volume":"356","author":"MJ Brown","year":"2000","unstructured":"Brown MJ, Palmer CR, Castaigne A et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine-GITS Study: Intervention as a goal in hypertension treatment (INSIGHT). Lancet 2000; 356: 366\u2013372","journal-title":"Lancet"},{"key":"402009_CR26","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1161\/01.HYP.35.5.1038","volume":"35","author":"MJ Brown","year":"2000","unstructured":"Brown MJ, Castaigne A, de Leeuw PW et al. Influence of diabetes and type of hypertension on response to antihyper-tensive treatment. Hypertension 2000; 35: 1038\u20131042","journal-title":"Hypertension"},{"key":"402009_CR27","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0140-6736(99)07330-4","volume":"355","author":"JA Staessen","year":"2000","unstructured":"Staessen JA, Gasowski J, Wang JL et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000; 355: 865\u2013872","journal-title":"Lancet"},{"key":"402009_CR28","first-page":"133","volume-title":"Clinical Hypertension","author":"NM. Kaplan","year":"1998","unstructured":"Kaplan NM. Treatment of hypertension: Rationale, guidelines, and goals. In: Kaplan NM, ed. Clinical Hypertension 7th ed. Baltimore, Williams and Wilkins 1998, pp. 133\u2013158","edition":"7th"},{"key":"402009_CR29","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/bmj.309.6952.436","volume":"309","author":"JM Geleijnse","year":"1994","unstructured":"Geleijnse JM, Witteman JCM, Bak AAA et al. Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension. Br Med J 1994; 309: 436\u2013440","journal-title":"Br Med J"},{"key":"402009_CR30","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1001\/archinte.1997.00440420033005","volume":"157","author":"Joint National Committee on Prevention, Detaction, Evalu-ationTreatment of High Blood Pressure.","year":"1997","unstructured":"Joint National Committee on Prevention, Detaction, Evalu-ation and Treatment of High Blood Pressure. The Six Report. Arch Intern Med 1997; 157: 2413\u20132446","journal-title":"The Six Report. Arch Intern Med"},{"key":"402009_CR31","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/jama.280.7.623","volume":"280","author":"HM Krumholz","year":"1998","unstructured":"Krumholz HM, Radford MJ, Wang et al. for the National Cooperative Cardiovascular Project. National use and effect-iveness of \u00e2-blockers for the treatment of elderly patients after acute myocardial infarction. JAMA 1998; 280: 623\u2013629","journal-title":"JAMA"},{"key":"402009_CR32","first-page":"307","volume-title":"Calcium Antagonists in Clin-ical Medicine","author":"B Burns","year":"1998","unstructured":"Burns B, Frishman W. Calcium antagonists in elderly patients with systemic hypertension. In Calcium Antagonists in Clin-ical Medicine 2nd ed. In: Epstein M, ed. Hanley & Belfus, Philadelphia 1998, pp. 307\u2013320","edition":"2nd"},{"issue":"13","key":"402009_CR33","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM200003303421301","volume":"342","author":"TW Gress","year":"2000","unstructured":"Gress TW, Nieto FJ, Shahar E et al. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. N Engl J Med 2000; 342(13): 905\u2013912","journal-title":"N Engl J Med"},{"issue":"9153","key":"402009_CR34","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0140-6736(98)05012-0","volume":"353","author":"L Hansson","year":"1999","unstructured":"Hansson L, Lindholm LH, Niskanen L et al. Effect of angiotensin converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial, Lancet 1999; 353(9153): 611\u2013616","journal-title":"Lancet"},{"issue":"3","key":"402009_CR35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","volume":"342","author":"S Yusuf","year":"2000","unstructured":"Yusuf S, Sleight P, Pogue J et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342(3): 145\u2013153","journal-title":"N Engl J Med"},{"key":"402009_CR36","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/00004872-200018060-00019","volume":"18","author":"C Farsang","year":"2000","unstructured":"Farsang C, Garcia-Puig J, Niegowska J et al. The efficacy and tolerability of losartan versus atenolol in patients with isolated systolic hypertension.J Hypertens 2000; 18: 795\u2013802","journal-title":"J Hypertens"},{"key":"402009_CR37","first-page":"110","volume":"2","author":"P Larochelle","year":"2000","unstructured":"Larochelle P, Smith DHG, Ouellet J et al. Efficacy and safety of omapatrilate in subjects with isolated systolic hypertension. Vasopeptidase Inhibition 2000; 2: 110\u2013111","journal-title":"Vasopeptidase Inhibition"},{"key":"402009_CR38","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1046\/j.1365-2125.1999.00070.x","volume":"48","author":"PO Lim","year":"1999","unstructured":"Lim PO, Jung RT, MacDonald TMM. Raised aldosterone to rennin ratio predicts antihypertensive efficacy of spiro-nolacone: a prospective cohort follow-up study. Br J Clin Pharmacol 1999; 48: 756\u2013760","journal-title":"Br J Clin Pharmacol"},{"key":"402009_CR39","first-page":"69","volume":"5","author":"ME. Safar","year":"1990","unstructured":"Safar ME. Antihypertensive effects of nitrates in chronic human hypertension. J Appl Cardiol 1990; 5: 69\u201381","journal-title":"J Appl Cardiol"},{"key":"402009_CR40","first-page":"151","volume":"17","author":"Guidelines Subcommittee","year":"1999","unstructured":"Guidelines Subcommittee. 1999 World Health Organization \u2013 International Society of Hypertension Guidelined for the management of hypertension. J Hypertens 1999; 17: 151\u2013183","journal-title":"J Hypertens"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1019552602793.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1019552602793\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1019552602793.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T06:06:13Z","timestamp":1754892373000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1019552602793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["402009"],"URL":"https:\/\/doi.org\/10.1023\/a:1019552602793","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"type":"print","value":"0301-1623"},{"type":"electronic","value":"1573-2584"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}